COVID-19 Impact: BMW, Fluor, MyEyeDr.
BMW, Fluor, and MyEyeDr. have been impacted by the COVID-19 crisis differently. The requested information about the companies is presented below.
- A direct link to the article can be found here. In response to the COVID-19 pandemic, BMW has taken the initiative to protect its employees, business, and taking responsibility for the society. Thus, the company is focusing on solidarity and flexibility in coping with the pandemic.
- A direct link to the article can be found here. Amid the COVID-19 pandemic, BMW CEO, Oliver Zipse, observes that the company is focused on preserving the health of its balance sheet and employees.
- A direct link to the article can be found here. Before the start of COVID-19, BMW expected its earnings before tax (EBT) to improve significantly. Nonetheless, due to the speedy spread of the virus, the company expects its EBT to decline significantly.
- A direct link to the article can be found here. BMW is offering payment deferment policies to attract buyers, who may be experiencing unexpected burdens during the COVID-19 crisis. The relief and incentive plans target both existing and prospective customers.
- A direct link to the article can be found here. The spread of COVID-19 pandemic had caused BMW shares in the German trading to plummet. The company has also projected an adverse impact on delivery volumes in all key markets.
- A direct link to the article can be found here. Fluor has adopted a poison pill to shield stockholders from efforts to leverage the ongoing volatility caused by the COVID-19 pandemic.
- A direct link to the article can be found here. Fluor’s major concern is the safety and health of its workers and the society. The company is also keen on following the guidelines offered by the World Health Organization, local and national governments, and Centers for Disease Control and Prevention (CDC).
- A direct link to the article can be found here. Fluor’s announcement of a poison pill adoption to address the volatility triggered by COVID-19 pandemic caused its shares to plummet to $6.23 per share on the New York Stock Exchange on March 25, 2020. Before that, the shares had a 12-month high of $41.56 per share.
- A direct link to the article can be found here. On March 19, 2020, MyEyeDr. temporarily closed all its offices in response to COVID-19 pandemic. The move was meant to protect its employees and the community.
- A direct link to the article can be found here. On April 2, 2020, MyEyeDr. extended the temporary closure to prevent the spread of coronavirus. The company also furloughed some staff members and associates, and executed other cost-saving measures.
- A direct link to the article can be found here. Amid the COVID-19 spread, MyEyeDr. prioritizes the safety and health of its employees, associates, patients, and the community in which it serves. Thus, the company is following the guidelines provided by CDC and other national health organizations.
- A direct link to the article can be found here. MyEyeDr. opened selected offices to attend to eye patients with immediate, essential needs despite the spreading COVID-19. The company understands that its patients need essential care.
- A direct link to the article can be found here. MyEyeDr’s optometrists and dentists have rescheduled their appointments as they exercise caution with COVID-19. The postponements are being made in the interest of the staff and patients’ health.
The research team mainly relied on current news articles about COVID-19 and its impact on the specified companies. The companies’ press releases also provided valuable information such as their response measures. However, the team only found three articles on Fluor Corporation. After an extensive search through the company’s recent press releases, its social media posts, and news articles, it was apparent that most of the articles focused on three common themes, namely a bitter pill adoption, market volatility, and falling shares prices as result of COVID-19 pandemic. Other articles with granular information on the impact of COVID-19 crisis on Fluor Corporation were paywalled. Probably, Fluor is not heavily affected by the pandemic considering that the demand for oil production is expected to increase amid the crisis.